Boehringer Ingelheim Loses Legal Challenge to IRA in Federal Court Ruling

A federal court last week ruled against Boehringer Ingelheim’s legal challenge to the Medicare Drug Price Negotiation Program, granting the Biden administration its latest victory over the pharma industry’s efforts to block the Inflation Reduction Act.